Use of sex-specific clinical and exercise risk scores to identify patients at increased risk for all-cause mortality

Paul C. Cremer, Yuping Wu, Haitham M. Ahmed, Lee M. Pierson, Danielle M. Brennan, Mouaz H. Al-Mallah, Clinton A. Brawner, Jonathan K. Ehrman, Steven J. Keteyian, Roger S Blumenthal, Michael Blaha, Leslie Cho

Research output: Contribution to journalArticle

Abstract

IMPORTANCE: Risk assessment tools for exercise treadmill testing may have limited external validity. Cardiovascular mortality has decreased in recent decades, and women have been underrepresented in prior cohorts. OBJECTIVES: To determine whether exercise and clinical variables are associated with differential mortality outcomes in men and women and to assess whether sex-specific risk scores better estimate all-cause mortality. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study included 59 877 patients seen at the Cleveland Clinic Foundation (CCF cohort) from January 1, 2000, through December 31, 2010, and 49 278 patients seen at the Henry Ford Hospital (FIT cohort) from January 1, 1991, through December 31, 2009. All patients were 18 years or older and underwent exercise treadmill testing. Data were analyzed from January 1, 2000, to October 27, 2011, in the CCF cohort and from January 1, 1991, to April 1, 2013, in the FIT cohort. MAIN OUTCOMES AND MEASUREMENTS: The CCF cohort was divided randomly into derivation and validation samples, and separate risk scores were developed for men and women. Net reclassification, C statistics, and integrated discrimination improvement were used to compare the sex-specific risk scores with other tools that have all-cause mortality as the outcome. Discrimination and calibration were also evaluated with these sex-specific risk scores in the FIT cohort. RESULTS: The CCF cohort included 59 877 patients (59.4% men; 40.5% women) with a median (interquartile range [IQR]) age of 54 (45-63) years and 2521 deaths (4.2%) during a median follow-up of 7 (IQR, 4.1-9.6) years. The FIT cohort included 49 278 patients (52.5% men; 47.4% women) with a median (IQR) age of 54 (46-64) years and 6643 deaths (13.5%) during a median (IQR) follow-up of 10.2 (7-13.4) years. C statistics for the sex-specific risk scores in the CCF validation sample were higher (0.79 in women and 0.81 in men) than C statistics using other tools in women (0.70 for Duke Treadmill Score; 0.74 for Lauer nomogram) and men (0.72 for Duke Treadmill Score; 0.75 for Lauer nomogram). Net reclassification and integrated discrimination improvement were superior with the sex-specific risk scores, mostly owing to correct reclassification of events. The sex-specific risk scores in the FIT cohort demonstrated similar discrimination (C statistic, 0.78 for women and 0.79 for men), and calibration was reasonable. CONCLUSIONS AND RELEVANCE: Sex-specific risk scores better estimate mortality in patients undergoing exercise treadmill testing. In particular, these sex-specific risk scores help to identify patients at the highest residual risk in the present era.

Original languageEnglish (US)
Pages (from-to)15-22
Number of pages8
JournalJAMA Cardiology
Volume2
Issue number1
DOIs
StatePublished - Jan 1 2017

Fingerprint

Exercise
Mortality
Nomograms
Calibration
Cohort Studies
Retrospective Studies

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Cremer, P. C., Wu, Y., Ahmed, H. M., Pierson, L. M., Brennan, D. M., Al-Mallah, M. H., ... Cho, L. (2017). Use of sex-specific clinical and exercise risk scores to identify patients at increased risk for all-cause mortality. JAMA Cardiology, 2(1), 15-22. https://doi.org/10.1001/jamacardio.2016.3720

Use of sex-specific clinical and exercise risk scores to identify patients at increased risk for all-cause mortality. / Cremer, Paul C.; Wu, Yuping; Ahmed, Haitham M.; Pierson, Lee M.; Brennan, Danielle M.; Al-Mallah, Mouaz H.; Brawner, Clinton A.; Ehrman, Jonathan K.; Keteyian, Steven J.; Blumenthal, Roger S; Blaha, Michael; Cho, Leslie.

In: JAMA Cardiology, Vol. 2, No. 1, 01.01.2017, p. 15-22.

Research output: Contribution to journalArticle

Cremer, PC, Wu, Y, Ahmed, HM, Pierson, LM, Brennan, DM, Al-Mallah, MH, Brawner, CA, Ehrman, JK, Keteyian, SJ, Blumenthal, RS, Blaha, M & Cho, L 2017, 'Use of sex-specific clinical and exercise risk scores to identify patients at increased risk for all-cause mortality', JAMA Cardiology, vol. 2, no. 1, pp. 15-22. https://doi.org/10.1001/jamacardio.2016.3720
Cremer, Paul C. ; Wu, Yuping ; Ahmed, Haitham M. ; Pierson, Lee M. ; Brennan, Danielle M. ; Al-Mallah, Mouaz H. ; Brawner, Clinton A. ; Ehrman, Jonathan K. ; Keteyian, Steven J. ; Blumenthal, Roger S ; Blaha, Michael ; Cho, Leslie. / Use of sex-specific clinical and exercise risk scores to identify patients at increased risk for all-cause mortality. In: JAMA Cardiology. 2017 ; Vol. 2, No. 1. pp. 15-22.
@article{08bb814313854345ad8a67168305be4e,
title = "Use of sex-specific clinical and exercise risk scores to identify patients at increased risk for all-cause mortality",
abstract = "IMPORTANCE: Risk assessment tools for exercise treadmill testing may have limited external validity. Cardiovascular mortality has decreased in recent decades, and women have been underrepresented in prior cohorts. OBJECTIVES: To determine whether exercise and clinical variables are associated with differential mortality outcomes in men and women and to assess whether sex-specific risk scores better estimate all-cause mortality. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study included 59 877 patients seen at the Cleveland Clinic Foundation (CCF cohort) from January 1, 2000, through December 31, 2010, and 49 278 patients seen at the Henry Ford Hospital (FIT cohort) from January 1, 1991, through December 31, 2009. All patients were 18 years or older and underwent exercise treadmill testing. Data were analyzed from January 1, 2000, to October 27, 2011, in the CCF cohort and from January 1, 1991, to April 1, 2013, in the FIT cohort. MAIN OUTCOMES AND MEASUREMENTS: The CCF cohort was divided randomly into derivation and validation samples, and separate risk scores were developed for men and women. Net reclassification, C statistics, and integrated discrimination improvement were used to compare the sex-specific risk scores with other tools that have all-cause mortality as the outcome. Discrimination and calibration were also evaluated with these sex-specific risk scores in the FIT cohort. RESULTS: The CCF cohort included 59 877 patients (59.4{\%} men; 40.5{\%} women) with a median (interquartile range [IQR]) age of 54 (45-63) years and 2521 deaths (4.2{\%}) during a median follow-up of 7 (IQR, 4.1-9.6) years. The FIT cohort included 49 278 patients (52.5{\%} men; 47.4{\%} women) with a median (IQR) age of 54 (46-64) years and 6643 deaths (13.5{\%}) during a median (IQR) follow-up of 10.2 (7-13.4) years. C statistics for the sex-specific risk scores in the CCF validation sample were higher (0.79 in women and 0.81 in men) than C statistics using other tools in women (0.70 for Duke Treadmill Score; 0.74 for Lauer nomogram) and men (0.72 for Duke Treadmill Score; 0.75 for Lauer nomogram). Net reclassification and integrated discrimination improvement were superior with the sex-specific risk scores, mostly owing to correct reclassification of events. The sex-specific risk scores in the FIT cohort demonstrated similar discrimination (C statistic, 0.78 for women and 0.79 for men), and calibration was reasonable. CONCLUSIONS AND RELEVANCE: Sex-specific risk scores better estimate mortality in patients undergoing exercise treadmill testing. In particular, these sex-specific risk scores help to identify patients at the highest residual risk in the present era.",
author = "Cremer, {Paul C.} and Yuping Wu and Ahmed, {Haitham M.} and Pierson, {Lee M.} and Brennan, {Danielle M.} and Al-Mallah, {Mouaz H.} and Brawner, {Clinton A.} and Ehrman, {Jonathan K.} and Keteyian, {Steven J.} and Blumenthal, {Roger S} and Michael Blaha and Leslie Cho",
year = "2017",
month = "1",
day = "1",
doi = "10.1001/jamacardio.2016.3720",
language = "English (US)",
volume = "2",
pages = "15--22",
journal = "JAMA Cardiology",
issn = "2380-6583",
publisher = "American Medical Association",
number = "1",

}

TY - JOUR

T1 - Use of sex-specific clinical and exercise risk scores to identify patients at increased risk for all-cause mortality

AU - Cremer, Paul C.

AU - Wu, Yuping

AU - Ahmed, Haitham M.

AU - Pierson, Lee M.

AU - Brennan, Danielle M.

AU - Al-Mallah, Mouaz H.

AU - Brawner, Clinton A.

AU - Ehrman, Jonathan K.

AU - Keteyian, Steven J.

AU - Blumenthal, Roger S

AU - Blaha, Michael

AU - Cho, Leslie

PY - 2017/1/1

Y1 - 2017/1/1

N2 - IMPORTANCE: Risk assessment tools for exercise treadmill testing may have limited external validity. Cardiovascular mortality has decreased in recent decades, and women have been underrepresented in prior cohorts. OBJECTIVES: To determine whether exercise and clinical variables are associated with differential mortality outcomes in men and women and to assess whether sex-specific risk scores better estimate all-cause mortality. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study included 59 877 patients seen at the Cleveland Clinic Foundation (CCF cohort) from January 1, 2000, through December 31, 2010, and 49 278 patients seen at the Henry Ford Hospital (FIT cohort) from January 1, 1991, through December 31, 2009. All patients were 18 years or older and underwent exercise treadmill testing. Data were analyzed from January 1, 2000, to October 27, 2011, in the CCF cohort and from January 1, 1991, to April 1, 2013, in the FIT cohort. MAIN OUTCOMES AND MEASUREMENTS: The CCF cohort was divided randomly into derivation and validation samples, and separate risk scores were developed for men and women. Net reclassification, C statistics, and integrated discrimination improvement were used to compare the sex-specific risk scores with other tools that have all-cause mortality as the outcome. Discrimination and calibration were also evaluated with these sex-specific risk scores in the FIT cohort. RESULTS: The CCF cohort included 59 877 patients (59.4% men; 40.5% women) with a median (interquartile range [IQR]) age of 54 (45-63) years and 2521 deaths (4.2%) during a median follow-up of 7 (IQR, 4.1-9.6) years. The FIT cohort included 49 278 patients (52.5% men; 47.4% women) with a median (IQR) age of 54 (46-64) years and 6643 deaths (13.5%) during a median (IQR) follow-up of 10.2 (7-13.4) years. C statistics for the sex-specific risk scores in the CCF validation sample were higher (0.79 in women and 0.81 in men) than C statistics using other tools in women (0.70 for Duke Treadmill Score; 0.74 for Lauer nomogram) and men (0.72 for Duke Treadmill Score; 0.75 for Lauer nomogram). Net reclassification and integrated discrimination improvement were superior with the sex-specific risk scores, mostly owing to correct reclassification of events. The sex-specific risk scores in the FIT cohort demonstrated similar discrimination (C statistic, 0.78 for women and 0.79 for men), and calibration was reasonable. CONCLUSIONS AND RELEVANCE: Sex-specific risk scores better estimate mortality in patients undergoing exercise treadmill testing. In particular, these sex-specific risk scores help to identify patients at the highest residual risk in the present era.

AB - IMPORTANCE: Risk assessment tools for exercise treadmill testing may have limited external validity. Cardiovascular mortality has decreased in recent decades, and women have been underrepresented in prior cohorts. OBJECTIVES: To determine whether exercise and clinical variables are associated with differential mortality outcomes in men and women and to assess whether sex-specific risk scores better estimate all-cause mortality. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study included 59 877 patients seen at the Cleveland Clinic Foundation (CCF cohort) from January 1, 2000, through December 31, 2010, and 49 278 patients seen at the Henry Ford Hospital (FIT cohort) from January 1, 1991, through December 31, 2009. All patients were 18 years or older and underwent exercise treadmill testing. Data were analyzed from January 1, 2000, to October 27, 2011, in the CCF cohort and from January 1, 1991, to April 1, 2013, in the FIT cohort. MAIN OUTCOMES AND MEASUREMENTS: The CCF cohort was divided randomly into derivation and validation samples, and separate risk scores were developed for men and women. Net reclassification, C statistics, and integrated discrimination improvement were used to compare the sex-specific risk scores with other tools that have all-cause mortality as the outcome. Discrimination and calibration were also evaluated with these sex-specific risk scores in the FIT cohort. RESULTS: The CCF cohort included 59 877 patients (59.4% men; 40.5% women) with a median (interquartile range [IQR]) age of 54 (45-63) years and 2521 deaths (4.2%) during a median follow-up of 7 (IQR, 4.1-9.6) years. The FIT cohort included 49 278 patients (52.5% men; 47.4% women) with a median (IQR) age of 54 (46-64) years and 6643 deaths (13.5%) during a median (IQR) follow-up of 10.2 (7-13.4) years. C statistics for the sex-specific risk scores in the CCF validation sample were higher (0.79 in women and 0.81 in men) than C statistics using other tools in women (0.70 for Duke Treadmill Score; 0.74 for Lauer nomogram) and men (0.72 for Duke Treadmill Score; 0.75 for Lauer nomogram). Net reclassification and integrated discrimination improvement were superior with the sex-specific risk scores, mostly owing to correct reclassification of events. The sex-specific risk scores in the FIT cohort demonstrated similar discrimination (C statistic, 0.78 for women and 0.79 for men), and calibration was reasonable. CONCLUSIONS AND RELEVANCE: Sex-specific risk scores better estimate mortality in patients undergoing exercise treadmill testing. In particular, these sex-specific risk scores help to identify patients at the highest residual risk in the present era.

UR - http://www.scopus.com/inward/record.url?scp=85020549865&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020549865&partnerID=8YFLogxK

U2 - 10.1001/jamacardio.2016.3720

DO - 10.1001/jamacardio.2016.3720

M3 - Article

C2 - 27784057

AN - SCOPUS:85020549865

VL - 2

SP - 15

EP - 22

JO - JAMA Cardiology

JF - JAMA Cardiology

SN - 2380-6583

IS - 1

ER -